CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.(CELZ)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.2M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CELZ Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ), a Healthcare sector company. CELZ is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.2m in revenue and is scored on the micro-cap board instead. Top institutional holders of CELZ by reported 13-F value include Hudson Bay Capital Management, Anson Funds Management, ARMISTICE CAPITAL, based on the most recent SEC filings. CELZ trades on the Nasdaq exchange and files with the SEC under CIK 1187953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CELZ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. directly from SEC EDGAR.
Revenue
Q2 2026
$0.00
Net Income
Q2 2026
$-1.5M
ROIC
Q2 2026
-72.2%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-45.5% YoYNet Income
-9.1% YoYOperating Income
-6.9% YoYEPS (Diluted)
+32.1% YoYTotal Assets
+17.1% YoYOp. Cash Flow
-10.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.0K -45.5% | $11.0K +22.2% | $9.0K -89.8% | $88.6K +1.0% | $87.8K -46.7% | $164.5K |
| Net Income | $-6.0M -9.1% | $-5.5M -3.9% | $-5.3M +47.9% | $-10.1M -152.8% | $19.2M +152.9% | $-36.3M |
| Operating Income | $-6.1M -6.9% | $-5.7M -2.2% | $-5.6M +45.1% | $-10.2M -227.7% | $-3.1M -180.4% | $-1.1M |
| EPS (Diluted) | $-2.52 +32.1% | $-3.71 +1.3% | $-3.76 -304.3% | $-0.93 -116.6% | $5.61 +108.9% | $-62.69 |
| Total Assets | $7.8M +17.1% | $6.7M -37.8% | $10.7M -44.2% | $19.2M +70.3% | $11.3M +1469.9% | $717.8K |
| Operating Cash Flow | $-5.9M -10.5% | $-5.3M +34.0% | $-8.0M -3.0% | $-7.8M -251.9% | $-2.2M -409.9% | $-434.6K |
Get alerted when CELZ's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. including:
Top Institutional Holders of CELZ
Hudson Bay Capital Management LP
$196.0K135,170 shAnson Funds Management LP
$153.0K105,549 shARMISTICE CAPITAL, LLC
$60.9K42,000 shXTX Topco Ltd
$38.5K26,559 shGEODE CAPITAL MANAGEMENT, LLC
$37.4K25,799 shVANGUARD CAPITAL MANAGEMENT LLC
$29.5K20,350 shVANGUARD FIDUCIARY TRUST CO
$8.0K5,518 shTower Research Capital LLC (TRC)
$7.0K4,853 shGlobal Retirement Partners, LLC
$6.0K4,118 shUBS Group AG
$3.0K2,061 sh
| Fund | Value | Shares |
|---|---|---|
| Hudson Bay Capital Management LP | $196.0K | 135,170 |
| Anson Funds Management LP | $153.0K | 105,549 |
| ARMISTICE CAPITAL, LLC | $60.9K | 42,000 |
| XTX Topco Ltd | $38.5K | 26,559 |
| GEODE CAPITAL MANAGEMENT, LLC | $37.4K | 25,799 |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.5K | 20,350 |
| VANGUARD FIDUCIARY TRUST CO | $8.0K | 5,518 |
| Tower Research Capital LLC (TRC) | $7.0K | 4,853 |
| Global Retirement Partners, LLC | $6.0K | 4,118 |
| UBS Group AG | $3.0K | 2,061 |
More Healthcare Companies
View all Healthcare →Put CELZ on your watchlist
Track score changes the day CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CELZ a good stock to buy?
13F Pro's AI-powered analysis of CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CELZ are available on the CELZ stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CELZ is classified as a small company.
Which hedge funds own CELZ?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CELZ. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s investment landscape.